Optic neuritis global clinical trials review, H1, 2015 published by leading ...
This report provides elemental information and data relating to the clinical trials on Optic Neuritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. "Optic Neuritis ...
WhaTech - Wed, 25 Mar 2015 20:45

Optic Neuritis Global Clinical Trials Review, H1, 2015 Market Research Report ...
Albany, NY -- (ReleaseWire) -- 03/02/2015 -- Clinical trial report, "Optic Neuritis Global Clinical Trials Review, H1, 2015"" provides data on the Optic Neuritis clinical trial scenario. This report provides elemental information and data relating to ...
Digital Journal - Mon, 02 Mar 2015 08:03

Statins for Multiple Sclerosis
... eight trials has been published, and the eligible studies included five in which statins were used along with interferon in remitting-relapsing MS and one each of statins only for clinically isolated syndrome (CIS), optic neuritis, and secondary ...
eMaxHealth - Mon, 30 Mar 2015 15:12

Syndax and Merck to Collaborate on Immuno-Oncology Study Evaluating ...
... with KEYTRUDA: exfoliative dermatitis, uveitis, arthritis, myositis, pancreatitis, hemolytic anemia, partial seizures arising in a patient with inflammatory foci in brain parenchyma, adrenal insufficiency, myasthenic syndrome, optic neuritis, and ...
Finances.com - Tue, 31 Mar 2015 05:00

Local comedy event to raise money, awareness for multiple sclerosis
“I have had issues with optic neuritis. It messes with my vision; in fact, I went for about four months being completely blind. There was a communication breakdown between my eyes and the brain telling me what I was seeing. I also have pain in my feet.
Shelbynews - Thu, 26 Mar 2015 12:41

Is It Time to Consider Selling Biogen?
But there's just one problem: Biogen's top-line data from its phase 2 study of anti-Lingo-1 in patients with acute optic neuritis wasn't really on point. The drug demonstrated an improvement in the recovery of optic nerve latency -- which is what ...
Investopedia - Tue, 24 Mar 2015 09:07

Drug Successfully Restores Myelin in Phase 2 Trial
Anti LINGO 1 showed improvement in the recovery of optic nerve latency when measured by FF VEP, which is the time for a signal to travel from the retina to the visual cortex, when compared to a placebo group. The researchers from the study also noted ...
HCPLive - Thu, 26 Mar 2015 09:07

Limited Success With Myelin Rebuilder in Optic Neuritis
Six weeks of treatment in a midstage clinical trial with a potential remyelination agent led to increases in a measure of optic nerve conduction in patients with acute optic neuritis, a condition often seen in conjunction with multiple sclerosis, the ...
MedPage Today - Thu, 08 Jan 2015 10:11

Biogen Reveals Positive Data from Acute Optic Neuritis Study
Zacks.com - Fri, 09 Jan 2015 13:33

Biogen Idec anti-LINGO-1 data in acute optic neuritis whet appetites for more
BioWorld Online - Thu, 08 Jan 2015 18:37

Biogen's Nerve Repair Drug Yields Mixed Results in Key Eye Trial
TheStreet.com - Thu, 08 Jan 2015 05:35

Biogen shares fall after optic nerve study results seen as mixed
Yahoo News - Thu, 08 Jan 2015 05:12

UPDATED: Biogen Idec's remyelination drug raises hopes--and fears--in PhII
FierceBiotech - Thu, 08 Jan 2015 05:28

1  2  3  4  5  6  7  8    ->

We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014